Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2005
09/01/2005CA2555421A1 Agonists and antagonists of p28 ebi3 and wsx/tccr for treating immune disorders
09/01/2005CA2555236A1 Methods of modulating cytokine activity; related reagents
09/01/2005CA2555210A1 Chemically programmable immunity
09/01/2005CA2555071A1 Histamine-3 receptor modulators
09/01/2005CA2554965A1 Antibodies specific for activated confirmation of lfa-1
09/01/2005CA2552433A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
09/01/2005CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production
08/2005
08/31/2005EP1568779A1 HSV strains for the oncolytic treatment of cancer
08/31/2005EP1568772A2 Human growth hormone variants
08/31/2005EP1568771A2 Human growth hormone variants
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof
08/31/2005EP1568692A1 (pyridin-4-yl)alkyl-amides as TNF-alpha production inhibitors
08/31/2005EP1567644A2 Tissue specific genes and gene clusters
08/31/2005EP1567171A1 New use of dextran sulfate
08/31/2005EP1567160A2 Method of treatment of myocardial infarction
08/31/2005EP1567157A1 Methods of using and compositions comprising immunomudulatory compounds for the treatment and management of myeloproliferative diseases
08/31/2005EP1567150A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
08/31/2005EP1567138A1 Use of diamide derivatives for inhibiting chronic tissue transplant rejection
08/31/2005EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1268445B1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
08/31/2005EP1240168B1 Bicyclic inhibitors of glycogen synthase kinase 3
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1078064B1 Compounds from moraxella catarrhalis
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005EP0941333B1 Immunogenic detoxified mutant e. coli lt-a toxin
08/31/2005EP0939653B1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
08/31/2005EP0786002B1 Intracellular isoform of the interleukin-1 receptor antagonist
08/31/2005EP0721345B1 Prostatic cancer vaccine
08/31/2005EP0721335B1 Mycophenolate mofetil high dose oral suspensions
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662509A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662262A Decoys for treating and/or preventing Th2 cytokine-related allergic diseases, GATA3 mutant proteins and pharmaceutical compositions comprising the decoys and the proteins
08/31/2005CN1662253A Packaged virus-like particles for use as adjuvants: method of preparation and use
08/31/2005CN1662251A Adjuvant enhanced immunotherapy
08/31/2005CN1662248A Compositions against inflammatory processes
08/31/2005CN1662245A (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
08/31/2005CN1662244A Powdery respiratory tonic composition
08/31/2005CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1662154A Probiotics and oral tolerance
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660906A Technique for extracting secretion type immunoglobulin sig A in extractive of human colostrum
08/31/2005CN1660881A New type molecules of immunization stimulus and preparation method
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660811A Compound of 1, 4-substituted benzenes and preparing method and application
08/31/2005CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment
08/31/2005CN1660414A Stable preparation of interferon
08/31/2005CN1660412A Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid
08/31/2005CN1660407A Liquid preparation containing penta peptide of thymus and preparing method
08/31/2005CN1660401A Preparation of vital qi drop pills of ageratum and preparing method
08/31/2005CN1660351A Combination of medication of containing astragalus root and dragon's blood resin and application
08/31/2005CN1660347A Yinhuang combination, oral taking preparation and injection preparation, preparing method and application
08/31/2005CN1660312A Recipe for treating secretory otitis media also allergic rhinitis and preparation method
08/31/2005CN1660168A Formula of Chinese traditional medicine for core of health care pillow
08/31/2005CN1660167A Effective part of astragalus, preparing method and application in pharmacy
08/31/2005CN1660140A Activity combination of marine life and application
08/31/2005CN1660107A Solid preparation taken through oral cavity of compound MEthoxyphEnaminE and preparation method
08/31/2005CN1660098A Combination of tablet to swallow of containing Cetirizine Hydrochloride
08/31/2005CN1660072A Quick dissolving solid injection of yew alkyl group, preparation method and application
08/31/2005CN1216992C Immunomodulators
08/31/2005CN1216900C Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
08/31/2005CN1216872C Quinazoline derivatives and pharmaceutical applications thereof
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216641C Monoclonal human matural antibodies
08/30/2005US6936718 Reacting with acid mixed with solvent; salt formation
08/30/2005US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
08/30/2005US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
08/30/2005US6936698 Genetically engineered immunoglobulin; for use in treatment of hematopoietic defects
08/30/2005US6936689 Peptide antagonists of zonulin and methods for use of the same
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936622 they are phosphodiesterase (PDE) inhibitors useful for treament of allergic rhinitis, crohn's disease, ulcerative colitis, rheumatoid arthritis, bronchitis, bronchial asthma, COPD, ARDS, psoriasis, eczema, and combination thereof thereof.
08/30/2005US6936620 Nitrogen compounds such as 5-(4-(Benzyloxy)benzyl)-5-methyl-2, 4,6(1H,3H,5H)-pyrimidinetrione, used as enzyme inhibitors, used as antiinflammatory agents
08/30/2005US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936603 Treating autoimmune diseases mediated by cathepsin S
08/30/2005US6936586 interleukin 10 (IL-10) agonists; treatment of pancreatitis, arthritis, gout, allergies, inflammations and ischemias; polypeptides
08/30/2005US6936263 Th1 inducing natural adjuvant for heterologous antigens
08/30/2005US6936255 adjuvant which is a preferential stimulator of TH1 cell response such as 3D-MPL and QS21
08/30/2005US6936250 Polysaccharide encapsualted antigen
08/30/2005US6936248 Methods of inhibiting GPR-9-6 function
08/30/2005CA2136331C New pharmaceutical uses of krill enzymes
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/30/2005CA1341489C Family of primate hematopoietic growth factors
08/25/2005WO2005078081A1 Use of compounds that regulate hdac6 tubulin deacetylase activity in the preparation of pharmaceutical compositions, method of identifying the aforementioned regulating compounds, said pharmaceutical compounds and applications thereof
08/25/2005WO2005078072A1 Regulatory cell controlling immunological activity of t cell
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077887A1 Novel method of synthesis and novel crystalline form of agomelatine and pharmaceutical compositions containing said form
08/25/2005WO2005077349A1 HUMAN β-DEFENSIN PRODUCTION ACCELERATOR
08/25/2005US20050187380 Method for treating Th2-mediated disease
1 ... 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 ... 1172